Back to Agenda
From Approval to Access: Integrating Patient Insights into Coverage Decisions
Session Chair(s)
June Cha, PHD, MPH
Policy Director, FasterCures, Milken Institute, United States
Despite advances, patient engagement (PE) in post-approval access decisions remains limited, complex, and unclear. This session examines how patients can offer value-based insights and explores pathways to strengthen PE in product access decisions.
Learning Objective : Identify existing opportunities to incorporate patient input into access determinations; Recognize patient-contributed information and data that could broaden the evidentiary base for CMS and other payers; Discuss the resources and frameworks needed for CMS to systematically and scientifically engage with patient communities.
Speaker(s)
June Cha, PHD, MPH
Policy Director, FasterCures, Milken Institute, United States
Vital Voices from Patients in Access Determination
Kristi Martin, MA, MPA
Director, Camber Collective, United States
Patients Engaging with CMS: Opportunities, challenges, and lessons learned
James Chambers, PHD, MPHARM, MSC
Professor, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, United States
Patient Perspectives: Are They Missing from Commercial Payer Drug Coverage Policies?
Campbell Hutton, MPH
Senior Vice President, Global Advocacy, Breakthrough T1D, United States
How Breakthrough T1D has Engaged CMS
Have an account?